Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share - Additional Information (Detail)

v3.22.2.2
Earnings per Share - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
2021 Equity Compensation Plan | Performance Stock Units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Share-based compensation arrangement by share-based payment award, additional shares issued     38,036  
Total fair value of vested shares     $ 955,000  
Share based compensation arrangement by share based payment award equity instruments other than options, grant date     Mar. 23, 2022  
2013 Equity Compensation Plan | Performance Stock Units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Share-based compensation arrangement by share-based payment award, additional shares issued       42,626
Total fair value of vested shares       $ 784,000
Share based compensation arrangement by share based payment award equity instruments other than options, grant date       Mar. 24, 2021
Stock options, expiration term from date of grant     3 years  
Share-based compensation arrangement by share based payment award, performance stock units aggregate grant fair value     $ 2,000  
Share-based compensation arrangement by share based payment award, performance stock units outstanding 104,599 66,563 104,599 66,563
Stock option awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted EPS (shares) 0 0